Expertise in
32
conditions

Dr. Steven Y. Liu

Oncology | Hematology
2925 Debarr Road, Suite 300, 
Anchorage, AK 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
32
conditions
2925 Debarr Road, Suite 300, 
Anchorage, AK 

Overview

Steven Liu is an Oncologist and a Hematologist practicing medicine in Anchorage, Alaska.

Dr. Liu is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Chronic T-Cell Leukemia (CTCL), Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Testicular Yolk Sac Tumor.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 4 clinical trials. Dr. Liu is currently accepting new patients.

Specialties

Oncology
Hematology

Licenses

Internal Medicine in AK

Hospital Affiliations

Alaska Regional Hospital
Central Peninsula General Hospital
Providence Kodiak Island Medical Ctr
Providence Alaska Medical Center
Mat-Su Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

2925 Debarr Road, Suite 300, Anchorage, AK 99508

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An Open Label, Multi-center Phase IIIb Study of Asciminib (ABL001) Monotherapy in Previously Treated Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation
An Open Label, Multi-center Phase IIIb Study of Asciminib (ABL001) Monotherapy in Previously Treated Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation
Enrollment Status: Completed
Publish Date: October 16, 2025
Intervention Type: Drug
Study Drug: ABL001
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Fuzuloparib+Abiraterone Acetate+Prednisone
Study Phase: Phase 3
EPIK-B4: A Phase II, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR During Treatment With Alpelisib (BYL719) in Combination With Fulvestrant in Participants With HR+, HER2-, Advanced Breast Cancer With a PIK3CA Mutation Following Progression on/After Endocrine-based Therapy
EPIK-B4: A Phase II, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR During Treatment With Alpelisib (BYL719) in Combination With Fulvestrant in Participants With HR+, HER2-, Advanced Breast Cancer With a PIK3CA Mutation Following Progression on/After Endocrine-based Therapy
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drugs: Alpelisib, Fulvestrant, Metformin, Dapagliflozin
Study Phase: Phase 2
P2 Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- MBC in Patients Who Have Shown Previous Disease Progression on a Nonsteroidal Aromatase Inhibitor, Fulvestrant and CDK 4/6 Inhibitor
P2 Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- MBC in Patients Who Have Shown Previous Disease Progression on a Nonsteroidal Aromatase Inhibitor, Fulvestrant and CDK 4/6 Inhibitor
Enrollment Status: Withdrawn
Publish Date: March 24, 2023
Intervention Type: Drug
Study Drugs: Sabizabulin, Exemestane, Everolimus, Selective estrogen receptor modulator
Study Phase: Phase 2
View 3 Less Clinical Trials

3 Total Publications

Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.
Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 02, 2025
Similar Doctors
Expertise in
10
conditions
Dr. Shannon L. Smiley
Oncology | Hematology
Expertise in
10
conditions
Dr. Shannon L. Smiley
Oncology | Hematology
Referral may be required
Before you request
3851 Piper Street, Suite U340, 
Anchorage, AK 
 (1.8 miles away)
907-562-0321
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Shannon Smiley is an Oncologist and a Hematologist practicing medicine in Anchorage, Alaska. Dr. Smiley is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Large-Cell Immunoblastic Lymphoma, and Multiple Myeloma. Dr. Smiley is currently accepting new patients.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required
Before you request
3851 Piper Street, Suite U264, 
Anchorage, AK 
 (1.8 miles away)
907-562-4673
Languages Spoken:
English, Castilian, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Melissa Hardesty is an Oncologist practicing medicine in Anchorage, Alaska. Dr. Hardesty is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Salpingo-Oophorectomy, and Reconstructive Urology Surgery. Dr. Hardesty is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required
Before you request
3851 Piper Street, Suite U264, 
Anchorage, AK 
 (1.8 miles away)
907-562-4673
Languages Spoken:
English, French, German, Portuguese
See accepted insurances
Accepting New Patients
Offers Telehealth

Joanie Hope is an Oncologist practicing medicine in Anchorage, Alaska. Dr. Hope is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Salpingo-Oophorectomy, and Hernia Surgery. Dr. Hope is currently accepting new patients.

Frequently Asked Questions about Dr. Steven Y. Liu

How do I make an appointment with Dr. Steven Y. Liu?

You can book an appointment with Dr. Steven Y. Liu by calling their office at 907-279-3155. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Steven Y. Liu a top-rated expert for Chronic T-Cell Leukemia (CTCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steven Y. Liu is classified as an Distinguished expert for Chronic T-Cell Leukemia (CTCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Steven Y. Liu specialize in?

While Dr. Steven Y. Liu is a Oncology, they have specific expertise in Chronic T-Cell Leukemia (CTCL), Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Steven Y. Liu participate in research or clinical trials?

Yes. Dr. Steven Y. Liu has published 3 articles and abstracts on conditions like Chronic T-Cell Leukemia (CTCL). You can view a list of Dr. Steven Y. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Steven Y. Liu accept my insurance?

Dr. Steven Y. Liu accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 907-279-3155 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Liu's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 25 Advanced Conditions
    View All 103 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile